For instance, in colon cancer, downregulation of m6A levels reduces YTHDF2-dependent mRNA degradation, leading to increased expression of its target gene, KIF26B, and facilitating colon cancer progression and metastasis [101]. The gene discussed is KIF26B; the disease is malignant colon neoplasm.